These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up. Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651 [TBL] [Abstract][Full Text] [Related]
12. Irreversible Electroporation for Treatment of Hepatocellular Carcinoma Adjacent to the Gallbladder. Herwald SE; Chen JH; Arellano RS J Vasc Interv Radiol; 2016 Jul; 27(7):1093-4. PubMed ID: 27338501 [No Abstract] [Full Text] [Related]
13. Introduction to Irreversible Electroporation--Principles and Techniques. Thomson KR; Kavnoudias H; Neal RE Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541 [TBL] [Abstract][Full Text] [Related]
14. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience. Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous Approach to Irreversible Electroporation of the Pancreas: Miami Protocol. Venkat S; Hosein PJ; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):153-8. PubMed ID: 26365545 [TBL] [Abstract][Full Text] [Related]
16. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. Cannon R; Ellis S; Hayes D; Narayanan G; Martin RC J Surg Oncol; 2013 Apr; 107(5):544-9. PubMed ID: 23090720 [TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation for the ablation of liver tumors: are we there yet? Charpentier KP Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618 [TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan. Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929 [TBL] [Abstract][Full Text] [Related]
19. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma. Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study. Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]